Sign in
4

Changes in Ownership

Immix Biopharma, Inc. Filed Acc 0001641172-25-016111

Options or other derivatives

  • Director acquired 33,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Chudnovsky Yekaterina Director 2025-06-20 Grant or award · Stock Option (Right to Buy) +33,000 33,000 D
Loading xslF345X05/ownership.xml…